Contact
Novartis Pharma NV/SA:
+ 32 (0)2 246 16 11
In case of an adverse event:
[email protected]
Phone number 24/h:
Bel: 0800 94 368
Lux: + 32 475 319 792
McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. They have evolved over time and it is anticipated that, in 2025, newly revised diagnostic criteria will become available for MS1,2.
Healthcare professionals: register now to access up-to-date information about MS treatment.